Concepedia

M Rinaldi-Carmona

MR

Statistics

Publications

12

Citations

2.2K

H-Index

12

Active since

1992

Affiliations

Sanofi (France)(Current)

M Rinaldi-Carmona is an author at Sanofi (France) specializing in pharmacology, cannabinoid pharmacology, and neuropharmacology.

Publications per year

1992–2002

12

Publications

12

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, Jean‐Marie Derocq et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 705 citations · Full text

, , +14

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Monsif Bouaboula, Caroline Poinot‐Chazel, B. Bourrié et al. · Biochemical Journal · 1995 · 539 citations · Full text

, , +14

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Jean-Paul Terranova, Jean-Jacques Storme, N. Lafon et al. · Psychopharmacology · 1996 · 287 citations

, , +14

Characterization of two cloned human CB1 cannabinoid receptor isoforms.

M Rinaldi-Carmona, Bernard Calandra, David Shire et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 122 citations

, , +14

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

M Rinaldi-Carmona, Christian Congy, Vincent Santucci et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 116 citations · Full text

, , +15

1–5 of 12